Last updated on October 2018

Rainbow Extension Study


Brief description of study

The purpose of this study is to evaluate the long term efficacy and safety of intravitreal ranibizumab compared with laser ablation therapy in patients who were treated for retinopathy of prematurity (ROP) in the core study CRFB002H2301

Clinical Study Identifier: NCT02640664

Find a site near you

Start Over

Novartis Investigative Site

Sacramento, CA United States
  Connect »

Novartis Investigative Site

Chicago, IL United States
  Connect »

Novartis Investigative Site

Louisville, KY United States
  Connect »

Novartis Investigative Site

Ann Arbor, MI United States
  Connect »

Novartis Investigative Site

Morgantown, WV United States
  Connect »

Novartis Investigative Site

Praha 4 - Podoli, Czechia
  Connect »

Novartis Investigative Site

Cheboksary, Russian Federation
  Connect »

Novartis Investigative Site

Kazan, Russian Federation
  Connect »

Novartis Investigative Site

Moscow, Russian Federation
  Connect »

Novartis Investigative Site

Soguksu / Antalya, Turkey
  Connect »

Novartis Investigative Site

Manchester, United Kingdom
  Connect »

Novartis Investigative Site

Portsmouth, United Kingdom
  Connect »

Novartis Investigative Site

Baltimore, MD United States
  Connect »

Novartis Investigative Site

Rochester, NY United States
  Connect »

Novartis Investigative Site

Saint-Petersburg, Russian Federation
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.